Kevin Kunzmann

Patients with mild infection are not at particular risk for severe, chronic outcomes from long Covid, according to new Israel data.

A cross-sectional study showed cannabis ingestion has been the cause of 1 in every 3 pediatric poisoning hospitalizations in provinces that sell edibles.

New data show patients who receive referred specialist care from a physician who went to medical school or other certification programs with their primary provider report better survey scores.

Qualitative interview analysis show male department chairs commonly witness discrimination against their female peers—yet they often are silent for a litany of reasons.

Michael J. Ackerman, MD, PhD, discusses the simplicity and availability of education around CPR and defibrillator use, and the role of clinicians in raising public health preparedness.

A Mayo Clinic cardiologist discusses the national variability in CPR and AED access, and the actions that saved Hamlin's life during Monday Night Football.

From a topical gene therapy to a debated heart failure option, a litany of unique agents are anticipated for FDA decision in the new year.

A new cross-sectional analysis suggest there are few options available for patients with schizophrenia or a serious mood disorder.

The approval for the non-surgical alternative was supported by phase 3 data showing ≥95% incidence eschar removal compared to a gel vehicle.

New longitudinal data support bolstered use of booster doses among health care workers in US nursing homes.

The FDA's plans to expedite and expand regulatory pathways has resulted in a novel drug development boom since 2017. The commissioner discusses the details of their strategy.

Meta-analysis data show female, Black and Asian participants are generally underrepresented across studies assessing COVID-19 prevention or treatment strategies.

The indication makes tocilizumab the first monoclonal antibody to be granted full FDA approval to treat the pandemic virus.

Lawrence Eichenfield, MD, reviews major drug approvals and advancement of screening and prevention strategies for the youngest patients with atopic dermatitis.

As 2022 concludes, a dermatologist reflects on the first drug approved for vitiligo.

New surveillance data from the 2021-22 influenza show the impact of coinfection among younger patients.

American Lung Association's Jennifer Folkenroth discusses the issues with "cold turkey," and what every habitual smoker should look for in a cessation plan.

A retrospective cohort analysis of patients in Finland show a notable overlap of the 2 forms of vision loss.

The indication expands the marketed use of the atypical antipsychotic drug to be used with antidepressants in adult patients.

A longitudinal, observational study shows chronic inflammatory disease patient scores for anxiety and sleep disturbance were bettered following doses of a SARS-CoV-2 vaccine.

An economic analysis of a clinical sleep intervention suggests it may provide a step toward improved health equity.

The American Lung Association ambassadors for tobacco cessation share best practices and their personal stories in this New Years resolution episode.

New phase 2 interim data show rates of the erectile condition were halved after 26 weeks of treatment.

The results for emotional functioning, social functioning, and nausea and vomiting numerically favored D-Rd at several time points.

Researchers from Germany suggest the utility of platelet and absolute neutrophil counts may be misplaced in current standards for pediatric remission.

A whole genomic sequencing study shows what may be influencing risk of quadruple-agent regimen response in patients receiving daratumumab.

The SPHRE trial in Tanzania show significant benefit for children at high stroke risk in sub-Saharan Africa.

An in vitro assessment showed the promising molecule class should be advanced toward prospective clinical trials.

Though avoidance of common food allergens is a popular practice among patients with atopic dermatitis, clinical trial evidence doesn't support its benefit compared to its risks.

Data show older men and women are getting less and less sleep. However, women are much more likely to report such issues than men, despite faring slightly better in polysomnography tests.